Press Release

2024

Featured News

Mankind Pharma Completes Landmark Acquisition of BSV

New Delhi, October 23, 2024

Mankind Pharma Limited has completed the transaction to acquire 100% stake in Bharat Serums and Vaccines Limited (BSV), for a purchase consideration of INR 13,768 Crores. This strategic move marks a significant leap for Mankind Pharma, positioning it as a market leader in the Indian women’s health and fertility drug market alongside access to other high entry barrier products in critical care segment with established complex R&D tech platforms.

BSV, FOGSI partner to increase awareness, access of colposcopy

June 3, 2024
ET Healthworld

Colposcopy enables healthcare providers to identify abnormal cervical cells early, often before they develop into cancer

READ MORE

Nexobrid: A revolutionary treatment for burns to treat patients in few hours

Feb 24, 2024

Bharat Serums and Vaccines (BSV), a biopharmaceutical company in India, has recently inked an exclusive distribution agreement with MediWound (NASDAQ: MDWD) to introduce NexoBrid, a groundbreaking treatment for severe…

READ MORE

NABICON 2024 focuses on novel treatments like NexoBrid for burn management

Feb 19, 2024

The National Academy of Burns organized the NABICON 2024 at Ranchi was held from February 15 to 17 to explore the recent advances in all aspects of burn prevention, burn wound management, burn reconstruction, rehabilitation and research….

READ MORE

BSV, FOGSI collaborate to increase breastfeeding, post-partum care awareness through RISHTA 2024 initiative

Feb 7, 2024

Mumbai: Bharat Serums and…

READ MORE

Re-Pharma Summit 2024: Revamping India’s pharma supply chains for resilience

Feb 2, 2024

The panel discussion, titled ‘From Manufacturing to Patient: Ensuring Seamless Pharma Supply Chains in India’, explored the complexities faced during the COVID-19 pandemic, the critical need for the availability of essential…

READ MORE

Budget 2024 reality pill: Amid cervical cancer vaccine buzz, no word on GST demand miffs health industry

Feb 1, 2024

Budget 2024: Dr Roderico H. Ofrin, WHO Representative to India, said that ASHA workers, Anganwadi workers, and helpers are at the forefront of health and care delivery at the grassroots level…

READ MORE

2023

Featured News

BSV, FOGSI organise the Run for gender equality

Dec 13, 2023

Part of a 28-city run, the initiative is aimed at connecting the country by spreading awareness for specific medical conditions such as anaemia…

READ MORE

Anaemia in India: Impact on reproductive health and tips to prevent it

Nov 30, 2023

Our body contains red blood cells (RBC), which are disc-shaped cells that transport oxygen to the various organs and tissues and a person with a low count of RBC is said to have anaemia…..

READ MORE

BSV launches adverse event reporting application

Sep 27, 2023

BSV AER is directly connected to BSV’s pharmacovigilance system, which allows healthcare professionals (HCPs), consumers and company personnel to report these electronically from their smartphones or tablets from any…

READ MORE

BSV breaks ground for ₹200 crore bio-pharmaceutical plant at Genome Valley

Sep 21, 2023

Biotech firm Bharat Serums and Vaccines (BSV) broke ground for a ₹200 crore bio-pharmaceutical manufacturing plant at Genome Valley in Hyderabad on Thursday…..

READ MORE

Bharat Serums and Vaccines holds groundbreaking ceremony for new plant in Telangana

Sep 21, 2023

BSV currently has a manufacturing facility in Ambernath, Maharashtra that caters to the domestic market and more than 80 export markets…

READ MORE

Bharat Serums to expand women’s health business in Southeast Asia, Africa

Aug 25, 2023

Bharat Serums and Vaccines will focus on South-East Asia and Africa as target markets for its women’s health and critical care products in the coming years…

READ MORE

BSV ropes in Bureau Veritas India Pvt Ltd as part of BSV ART Act Readiness Programme

Jul 26, 2023

The programme will assess the current state of these centres against six critical parameters: infrastructure; people and competency management; communication; patient and process selection…

READ MORE

ETHealthworld Fertility Conclave 2023: Understanding persisting fertility issues in India

Feb 21, 2023

In our efforts to normalise the fertility conversation and transform it into a holistic dialogue, ETHealthworld brought prolific players of…

READ MORE

ETHealthworld Fertility Conclave 2023 convening fertility experts to deliberate on challenges, advancements and future

Feb 20, 2023

ETHealthworld presents the third edition of the Fertility Conclave, key players of the fertility ecosystem including fertility experts, researchers, pharmaceutical…

READ MORE

Amp Energy India commissions open-access solar project for Bharat Serums and Vaccines

Feb 6, 2023

Amp Energy India announced this week it has commissioned a 5 MW solar power plant for Bharat Serum and Vaccines Ltd (BSV), one of India’s leading vaccine biopharmaceutical majors…

READ MORE

2022

Featured News

Bharat Serums and Vaccines will acquire Firstline Pharma, Genomicks to enhance its presence in women’s health segment

Dec 15, 2022

Bharat Serums and Vaccines Limited (BSV) on Thursday said that it has entered into a definitive…

READ MORE

Bharat Serums and Vaccines’ antibody Covid treatment in Phase 2 trials

Jan 7, 2022

Biopharmaceutical company Bharat Serums and Vaccines (BSV) has expanded its research and development facilities and capabilities, with its work on…

READ MORE

Advent International emerges sole bidder for Bharat Serums

Jun 22, 2022

Kotak PE and OrbiMed together hold 23% stake in BSV. The rest of the stake is with the Daftary family…

READ MORE

BSV forges industry-academia collaboration with National Chemical Laboratory

Jun 12, 2022

The collaboration focuses on evaluation of certain recombinant cell line technologies developed by NCL for biopharmaceutical products currently under development at BSV…

READ MORE

Bharat Serums and Vaccines acquires key women health brand Tidilan from Jagdale Industries

Apr 5, 2022

Tidilan is used for relaxing uterine muscles to prevent premature labour, among expecting mothers. It belongs to a class of medication…

READ MORE

TTK Healthcare to sell human pharma biz to Bharat Serums

Mar 22, 2022

Chennai-based TTK Healthcare is set to sell its human pharma division to Mumbai-based Bharat Serums and Vaccines (BSV) for Rs 805 crore…

READ MORE

Women’s Right to Good Health

Jun 12, 2022

For every mother who loses her life due to childbirth-related reasons, several more suffer from lack of access to healthcare. Effective continuum of care for mothers…

READ MORE

Insurance coverage can augment IVF, making it more accessible

Apr 3, 2022

The issue of insurance in the healthcare industry, notably in the IVF sector, was explored. Panellists spoke about how to navigate the cost for patients and bring…

READ MORE

Co-Creating Futuristic Manifesto for Fertility Care in India

Feb 25, 2022

Top thought leaders participating in the 2nd virtual edition of ETHealthworld Fertility Conclave Powered by Bharat Serums and Vaccines Ltd deliberate…

READ MORE

2021

Featured News

DGCI approves anti-fungal medicine for Covid-linked black fungus treatment

Mar 15, 2023

A Mumbai-based bio-pharmaceutical firm has received approval from India’s drug regulatory authority to use an anti-fungal drug for the treatment of black fungus or Mucormycosis…

READ MORE

For media inquiries, please contact Ms. Disha Karkera at  disha.karkera@bsvgroup.com